Weiner F, Schille JT, Hein JI, Wu XF, et al. Evaluation of combination protocols of the chemotherapeutic agent FX-9 with azacitidine, dichloroacetic acid, doxorubicin or carboplatin on prostate carcinoma cell lines. PLoS One 2021;16:e0256468.
PMID: 34432846